LivaNova (LIVN) Non Operating Investment Income (2017 - 2018)
LivaNova (LIVN) reported Non Operating Investment Income of $11.5 million for Q1 2018, down 70.87% sequentially from $39.4 million in Q2 2017.
LivaNova (LIVN) Non Operating Investment Income (2017 - 2018) Analysis & Trends
LivaNova (LIVN) has 2 years of Non Operating Investment Income data on file, last reported at $11.5 million in Q1 2018.
- For the quarter ending Q1 2018, Non Operating Investment Income changed N/A year-over-year to $11.5 million; the trailing twelve-month figure through Dec 2018 stood at $11.5 million (down 70.87% YoY), and the FY2018 full-year result was $11.5 million, down 70.87% from the prior year.
- Non Operating Investment Income slipped to $11.5 million in Q1 2018, from $39.4 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $39.4 million in Q2 2017 to a low of $11.5 million in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 11.48 Mn |
| Mar 31, 2018 | 11.48 Mn |
| Jun 30, 2017 | 39.43 Mn |
| Jun 30, 2017 | 39.43 Mn |